Beating Back the Coronavirus: FDA-Approved Drug Repurposing Pipeline



July 2, 2020

With the goal of rapidly repurposing FDA-approved drugs to treat COVID-19, the Wyss Institute is collaborating with the Frieman Lab at the University of Maryland Medical School and the tenOever Lab at the Icahn School of Medicine at Mount Sinai to establish a multidisciplinary pipeline that can rapidly predict, test, and validate potential treatments.

For more information, please visit:

Credit: Wyss Institute at Harvard University

Drug DiscoveryFlow ChemistryGenomicsStem Cells
Playlists featuring Wyss Institute for Biologically Inspired Engineering at Harvard University

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.